LDHA and glioblastoma: Based on the nature (e.g., well-tolerated in patients and BBB penetrating ability) of the two compounds, coupled with their anti-tumor effect in glioblastoma mouse and PDX models, we anticipate a tremendous translational potential of LDHA inhibition to improve patient outcomes.